Growth hormone receptor blockers

Somavert 25 mg lyophilized powder for injection Images

Generic Name: pegvisomant

This medication has been identified as Somavert 25 mg lyophilized powder for injection. It is supplied by Pfizer Inc.

Somavert is used in the treatment of Acromegaly and belongs to the drug class growth hormone receptor blockers. There is no proven risk in humans during pregnancy. Somavert 25 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).

Images

Somavert (Pegvisomant [ peg-vih-so-mant ])-medicine-25 mg lyophilized powder for injection

Somavert
Generic Name: pegvisomant [ peg-vih-so-mant ]
Imprint: medicine
Strength: 25 mg lyophilized powder for injection
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Growth hormone receptor blockers
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00009-5201
Inactive Ingredients:
Latest News
Related Drugs